SCHEMBL5148538

SCHEMBL5148538

CC(C)n1ncc(CNC(=O)OC(C)(C)C)c1NC(c1ccccc1)(c1ccccc1)c1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNA5 P22460 1/20 0.41
KDM4A O75164 1/20 0.37
NTSR1 P30989 1/20 0.36
PCSK9 Q8NBP7 1/20 0.36
HDAC10 Q969S8 1/20 0.36
HDAC6 Q9UBN7 1/20 0.36
NAMPT P43490 2/20 0.36
CKS1B P61024 1/20 0.36
SKP1 P63208 1/20 0.36
SKP2 Q13309 1/20 0.36
KDM4E B2RXH2 1/20 0.35
LMNA P02545 1/20 0.35
POLB P06746 1/20 0.35
MAPK1 P28482 1/20 0.35
ATM Q13315 1/20 0.35
SCN9A Q15858 1/20 0.35
SCD O00767 1/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
TRPV1 Q8NER1 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5147587 0.84 CKS1B (0.38) KCNA5KDM4AHDAC10HDAC6NAMPT
SCHEMBL5151955 0.82 DRD2 (0.39) KCNA5KDM4AHDAC10HDAC6CKS1B
SCHEMBL5148583 0.82 CKS1B (0.37) KCNA5KDM4AHDAC10HDAC6NAMPT
SCHEMBL5148509 0.79 KDM4A (0.34) KCNA5KDM4AHDAC10HDAC6NAMPT
SCHEMBL5148605 0.74 SIGMAR1 (0.43) NAMPTCKS1BSKP1SKP2MEN1
SCHEMBL5496197 0.70 SIGMAR1 (0.38) NAMPTCKS1BSKP1SKP2MEN1
SCHEMBL8018113 0.69 KCNA5 (0.56) KCNA5KDM4AHDAC10HDAC6NAMPT
SCHEMBL30159605 0.69 KCNA5 (0.56) KCNA5KDM4AHDAC10HDAC6NAMPT
SCHEMBL5492718 0.69 BCHE (0.40) NAMPTCKS1BSKP1SKP2LMNA
SCHEMBL5151807 0.69 RORC (0.35) NAMPTCKS1BSKP1SKP2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7179801-B2 Cephem compounds ASTELLAS PHARMA INC. (JP) 2007-02-20 US disclosed
EP-1392704-B1 CEPHEM COMPOUNDS ASTELLAS PHARMA INC (JP) 2006-02-22 EP disclosed
US-20040248875-A1 Cephem compounds ASTELLAS PHARMA INC. (JP) 2004-12-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040248875-A1 Cephem compounds CEP170, C1S, SLC7A1 KCNA5 2697/4885KDM4A 3374/4885NTSR1 3268/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.